Top compounds associated with response to CDC6


Feature Type Standardized
Nominal ANOVA
mRNA YM-155 GDSC1000 pan-cancer AAC 0.019 0.6
mRNA CIL55A CTRPv2 pan-cancer AAC 0.029 0.6
mRNA momelotinib CTRPv2 pan-cancer AAC 0.019 0.6
mRNA PD173074 GDSC1000 pan-cancer AAC 0.02 0.6
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.6
mRNA PF-4800567 hydrochloride CTRPv2 pan-cancer AAC -0.03 0.6
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.019 0.6
mRNA palmostatin B CTRPv2 pan-cancer AAC -0.025 0.6
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.018 0.6
mRNA Erlotinib UHNBreast pan-cancer AAC 0.16 0.6
Download CSV